Soluble endoglin contributes to the pathogenesis of preeclampsia

Venkatesha, Shivalingappa, Toporsian, Mourad, Lam, Chun, Hanai, Jun-ichi, Mammoto, Tadanori, Kim, Yeon M, Bdolah, Yuval, Lim, Kee-Hak +11 more·2006·Nature Medicine

Cited by (1,000)

Items 401–500 of 1,000

  1. Neonatal Exposure of Rats to Antidepressants Affects Behavioral Reactions to Novelty and Social Interactions in a Manner Analogous to Autistic Spectrum Disorders
    Federico E Rodriguez‐Porcel, DONALD PHILIP GREEN, Nidhi Khatri, Sharonda Harris, Warren L. May, Rick C.S. Lin, Ian A. Paul · 2011 · The Anatomical Record
  2. Detection of global DNA methylation and paternally imprinted H19 gene methylation in preeclamptic placentas
    Wenlong Gao, Dong Li, Zhongxin Xiao, Qin-ping Liao, Hui-xia Yang, Yu‐xia Li, Lei Ji, Yanling Wang · 2011 · Hypertension Research
  3. Disrupted Balance of Angiogenic and Antiangiogenic Signalings in Preeclampsia
    Mitsuko Furuya, Kentaro Kurasawa, Kiyotaka Nagahama, Kae Kawachi, Akinori Nozawa, Tsuneo A Takahashi, Ichiro Aoki · 2011 · Journal of Pregnancy
  4. Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia
    Guangfeng Zhao, Xue Zhou, Shiwen Chen, Huishuang Miao, Hongye Fan, Zhi­qun Wang, Yali Hu, Yayi Hou · 2014 · Journal of Biomedical Science
  5. Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
    Natalie J. Hannan, Fiona Brownfoot, Ping Cannon, Minh Deo, Sally Beard, Tuong Vi Nguyen, Kirsten Rebecca Palmer, Stephen Y. C. Tong, Tu’uhevaha J. Kaitu’u‐Lino · 2017 · Scientific Reports
  6. NLRP3 Deficiency Improves Angiotensin II-Induced Hypertension But Not Fetal Growth Restriction During Pregnancy
    Koumei Shirasuna, Tadayoshi Karasawa, Fumitake Usui, Motoi Kobayashi, Tadanori Komada, Hiroaki J. Kimura, Akira Kawashima, Akihide Ohkuchi, Shun’ichiro Taniguchi, Masafumi Takahashi · 2015 · Endocrinology
  7. Circulating Angiogenic Modulatory Factors Predict Survival and Functional Class in Pulmonary Arterial Hypertension
    Rajeev Kumar Malhotra, Samuel D Paskin-Flerlage, Roham T. Zamanian, Patrick Zimmerman, Jonathan W. Schmidt, Donna Y. Deng, Mark R. Southwood, Robert Spencer, Carol S. C. Lai, William Parker et al. · 2013 · Pulmonary Circulation
  8. Tumor necrosis factor α induces a model of preeclampsia in pregnant baboons (Papio hamadryas)
    Neroli Sunderland, Sally E. Thomson, Scott J. Heffernan, Shirlene M. Lim, John F. Thompson, Robert F. Ogle, Paul R. McKenzie, Paul J. Kirwan, Angela Makris, Annemarie Hennessy · 2011 · Cytokine
  9. Cellular Microparticles as a Marker for Cerebral Vasospasm in Spontaneous Subarachnoid Hemorrhage
    Peter Lackner, Anelia Dietmann, Ronny Beer, Marlene Fischer, Gregor Broessner, Raimund Helbok, J. Marxgut, Bettina Pfausler, Erich Schmutzhard · 2010 · Stroke
  10. Metabolic disorder of pregnancy (understanding pathophysiology of diabetes and preeclampsia).
    Liat Salzer, K. Tenenbaum-Gavish, M. Hod · 2015 · Best Practice & Research: Clinical Obstetrics & Gynaecology
  11. Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: The intersection of clinical, pathological, and high-dimensional biology studies
    Nándor Gábor Than, Máté Posta, Dániel Györffy, László Orosz, Gergő Orosz, Simona W. Rossi, Géza Ambrus-Aikelin, András Szilágyi, Sándor Nagy, Petronella Hupuczi et al. · 2022 · Placenta
  12. Preeclampsia and Obesity—The Preventive Role of Exercise
    Elżbieta Poniedziałek‐Czajkowska, Radzisław Mierzyński, Bożena Leszczyńska‐Gorzelak · 2023 · International Journal of Environmental Research and Public Health
  13. Gestational Diabetes and Hypertensive Disorders of Pregnancy as Vascular Risk Signals: An Overview and Grading of the Evidence
    Kara A. Nerenberg, Stella Styliani Daskalopoulou, Kaberi Dasgupta · 2014 · Canadian Journal of Cardiology
  14. HELLP babies link a novel lincRNA to the trophoblast cell cycle
    Marie van Dijk, Hari K. Thulluru, Joyce Mulders, Omar J. Michel, Ankie Poutsma, Sandra Windhorst, Gunilla Kleiverda, Daoud Sie, Augusta M.A. Lachmeijer, Cees B.M. Oudejans · 2012 · Journal of Clinical Investigation
  15. Resolved
    Barbara J. Ballermann · 2007 · Journal of the American Society of Nephrology
  16. Pregnancy-related thrombotic microangiopathies: Clues from complement biology
    Fádi Fakhouri · 2016 · Transfusion and Apheresis Science
  17. TGF ‐β superfamily co‐receptors in cancer
    John B. Pawlak, Gerard C. Blobe · 2021 · Developmental Dynamics
  18. Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1
    Melissa Cudmore, Shakil Ahmad, Samir Sissaoui, Wenda Ramma, Bin Ma, Takeshi Fujisawa, Bahjat Al‐Ani, Keqing Wang, M. Cai, F. Crispi et al. · 2011 · European Heart Journal
  19. Epigenetics and microRNAs in Preeclampsia
    Mahua Choudhury, Jacob E. Friedman · 2012 · Clinical and Experimental Hypertension
  20. Inhibition of VEGF or TGF-β Signaling Activates Endothelium and Increases Leukocyte Rolling
    Tony E. Walshe, Vandana S. Dole, Arindel S.R. Maharaj, Ian Sean Patten, Denisa D. Wagner, Patrìcia A. D'Amore · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
  21. Asymmetric dimethylarginine, arginine and homoarginine at 11–13 weeks’ gestation and preeclampsia: a case–control study
    Asma A. Khalil, Dimitrios Tsikas, Ranjit Akolekar, Jens Jordan, Kypros H. Nicolaides · 2011 · Journal of Human Hypertension
  22. Endoglin-Mediated Vascular Remodeling: Mechanisms Underlying Hereditary Hemorrhagic Telangiectasia
    Franck Lebrin, Christine L. Mummery · 2008 · Trends in Cardiovascular Medicine
  23. A Single Sphingomyelin Species Promotes Exosomal Release of Endoglin into the Maternal Circulation in Preeclampsia
    Leonardo Ermini, Jonathan Ausman, Megan Melland‐Smith, Behzad Yeganeh, Alessandro Rolfo, Michael L. Litvack, Tullia Todros, Michelle Letarte, Martin Post, Isabella Caniggia · 2017 · Scientific Reports
  24. The role of endoglin in post-ischemic revascularization
    Elena Núñez-Gómez, Miguel Pericacho, Claudia Ollauri-Ibáñez, Carmelo Bernabéu, José Miguel López-Novoa · 2016 · Angiogenesis
  25. A Systematic Review of Vascular Structure and Function in Pre-eclampsia: Non-invasive Assessment and Mechanistic Links
    Shady Kirollos, Michael R. Skilton, Sanjay Patel, Clare Gabrielle Arnott · 2019 · Frontiers in Cardiovascular Medicine
  26. Placental cytokines and preeclampsia
    Jeffrey A. Keelan · 2006 · Frontiers in bioscience
  27. Adiponectin in severe preeclampsia
    Jyh Kae Nien, Shali Mazaki‐Tovi, Roberto J. Romero, Offer Erez, Juan Pedro Kusanovic, Francesca Gotsch, Beth L. Pineles, Ricardo Gómez, Samuel S. Edwin, Moshe Mazor et al. · 2007 · Journal of Perinatal Medicine
  28. Matrix Metalloproteinase Enhances Big-Endothelin-1 Constriction in Mesenteric Vessels of Pregnant Rats With Reduced Uterine Blood Flow
    Ali Abdalvand, Jude S. Morton, Stephane Louis Bourque, Anita Quon, Sandra Thomas Davidge · 2013 · Hypertension
  29. Effect of Antihypertensive Therapy with Alpha Methyldopa on Levels of Angiogenic Factors in Pregnancies with Hypertensive Disorders
    Asma A. Khalil, Shanthi Muttukrishna, Kevin Harrington, Eric R. M. Jauniaux · 2008 · PLoS ONE
  30. The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia—Review
    Weronika Dymara-Konopka, Marzena Laskowska · 2019 · International Journal of Molecular Sciences
  31. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling
    Simon Tual‐Chalot, Maria Garcia-Collado, Rachael E. Redgrave, Esha Singh, Benjamin Davison, Catherine Park, Hua Lin, Saimir Luli, Yi Jin, Yixin Wang et al. · 2019 · Circulation Research
  32. Human placental cytotrophoblast epigenome dynamics over gestation and alterations in placental disease
    Bo Zhang, M. Yvonne Kim, GiNell Elliot, Yan Zhou, Guangfeng Zhao, Daofeng Li, Rebecca F. Lowdon, Matthew J. Gormley, Mirhan Kapidzic, Joshua F. Robinson et al. · 2021 · Developmental Cell
  33. In Vitro and In Vivo Evidence for Lack of Endovascular Remodeling by Third Trimester Trophoblasts
    Satyan S. Kalkunte, Z. Lai, Neetu Tewari, C.O. Chichester, Roberto J. Romero, James F. Padbury, Surendra Sharma · 2008 · Placenta
  34. Sildenafil citrate decreases sFlt-1 and sEng in pregnant l-NAME treated Sprague–Dawley rats
    Shamal Ramesar, Irene Mackraj, Prem Gathiram, Jagidesa Moodley · 2011 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  35. Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury
    Eunate Gallardo‐Vara, Francisco Javier Blanco, Mercè Roqué, Scott L. Friedman, Toru Suzuki, Luisa M. Botella, Carmelo Bernabéu · 2016 · Angiogenesis
  36. Innate Immune System at the Maternal–Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes
    Paola Triggianese, Carlo Perricone, Maria Sole Chimenti, Caterina De Carolis, Roberto Perricone · 2016 · American Journal of Reproductive Immunology
  37. Hypertensive Disorders of Pregnancy
    Sahar Naderi, Sandra A. Tsai, Abha Khandelwal · 2017 · Current Atherosclerosis Reports
  38. Human placental growth hormone in normal and abnormal fetal growth
    Alexandros Velegrakis, Maria Sfakiotaki, Stavros Sifakis · 2017 · Biomedical Reports
  39. The role of arginine, homoarginine and nitric oxide in pregnancy
    Asma A. Khalil, Lotte Hardman, Pat O’Brien · 2015 · Amino Acids
  40. Pre-eclampsia has an adverse impact on maternal and fetal health
    Saunders Lin, Dean Leonard, Mary Antonette M. Co, Dhriti Mukhopadhyay, Badri Giri, Lena Perger, Madhava Beeram, Thomas J. Kuehl, Mohammad Nasir Uddin · 2014 · Translational research
  41. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age
    Tinnakorn Chaiworapongsa, Roberto J. Romero, Francesca Gotsch, Jimmy Espinoza, Jyh Kae Nien, Luis Flavio Gonçalves, Samuel S. Edwin, Yeon Mee Kim, Offer Erez, Juan Pedro Kusanovic et al. · 2008 · The Journal of Maternal-Fetal & Neonatal Medicine
  42. Uncoupled Endothelial Nitric Oxide Synthase and Oxidative Stress in a Rat Model of Pregnancy-Induced Hypertension
    B MITCHELL, Leslie G. Cook, Svitlana D. Danchuk, Jules B. Puschett · 2007 · American Journal of Hypertension
  43. Change in Amniotic Fluid Levels of Multiple Anti-Angiogenic Proteins before Development of Preeclampsia and Intrauterine Growth Restriction
    Chao‐Nin Wang, Shuenn‐Dyh Chang, Hsiu‐Huei Peng, Yun‐Shien Lee, Yao‐Lung Chang, Po‐Jen Cheng, An‐Shine Chao, Tzu‐Hao Wang, Hsin‐Shih Wang · 2010 · The Journal of Clinical Endocrinology & Metabolism
  44. Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology
    Jana Auer, Luc Camoin, François Guillonneau, Virginie Rigourd, Sonia Tassadit Chelbi, Marjorie Leduc, Jérôme Laparre, Thérèse-Marie Mignot, Daniel Vaiman · 2010 · Journal of Proteomics
  45. Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule
    Friedrich Cameron Luft · 2006 · Nephrology Dialysis Transplantation
  46. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta
    Fiona Brownfoot, Stephen Y. C. Tong, Natalie J. Hannan, Roxanne M. Hastie, Ping Cannon, Tu’uhevaha J. Kaitu’u‐Lino · 2016 · BMC Pregnancy and Childbirth
  47. Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women
    Yongxin Yu, Alicia Josephine Jenkins, Alison J Nankervis, Kristian Folkvord Hanssen, Hanne Scholz, Tore Henriksen, Bjørg Lorentzen, Torun Clausen, Satish K. Garg, M. Kathryn Menard et al. · 2008 · Diabetologia
  48. Mechanism of hypertension and proteinuria during angiogenesis inhibition
    Stephanie Lankhorst, Mariëtte H.W. Kappers, Joep H.M. van Esch, A.H. Jan Danser, Anton H. van den Meiracker · 2012 · Journal of Hypertension
  49. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling
    Steffen K. Meurer, Lidia Tihaa, Erawan Borkham‐Kamphorst, Ralf Weiskirchen · 2010 · Cellular Signalling
  50. The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia
    Tereza Cindrová‐Davies · 2014 · Frontiers in Pharmacology
  51. Decreased Levels of Folate Receptor‐β and Reduced Numbers of Fetal Macrophages ( H ofbauer Cells) in Placentas from Pregnancies with Severe Pre‐Eclampsia
    Zhonghua Tang, Irina Alexandra Buhimschi, Catalin Sorin Buhimschi, Serkalem Tadesse, Errol R. Norwitz, Tracy Niven‐Fairchild, Se-Te Joseph Huang, Seth M. Guller · 2013 · American Journal of Reproductive Immunology
  52. Animal models of preeclampsia: translational failings and why
    Sarah A. Marshall, Natalie J. Hannan, Maria Jelinic, T. Nguyen, Jane E. Girling, Laura J. Parry · 2017 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  53. Super-enhancer-guided mapping of regulatory networks controlling mouse trophoblast stem cells
    Bum‐Kyu Lee, Yu Jin Jang, Mijeong Kim, Lucy LeBlanc, Catherine Rhee, Jiwoon Lee, Samuel J. Beck, Wenwen Shen, Jonghwan Kim · 2019 · Nature Communications
  54. Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?
    Asif Ahmed, Melissa Cudmore · 2009 · Biochemical Society Transactions
  55. The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?
    María González-Núñez, José M. Muñoz‐Félix, José Miguel López-Novoa · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  56. Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases
    Tomokazu Ikemoto, Yukihiro Hojo, Hideyuki Kondo, Nozomu Takahashi, Masahiro Hirose, Yoshioki Nishimura, Takaaki Katsuki, Kazuyuki Shimada, Kazuomi Kario · 2011 · Heart and Vessels
  57. The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome
    Brett C. Young, Richard J. Levine, Saira Salahuddin, Cong Qian, Kee-Hak Lim, S. Ananth Karumanchi, Sarosh Rana · 2009 · The Journal of Maternal-Fetal & Neonatal Medicine
  58. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: Soluble Tie-2
    Francesca Gotsch, Roberto J. Romero, Juan Pedro Kusanovic, Tinnakorn Chaiworapongsa, Michael Dombrowski, Offer Erez, Nándor Gábor Than, Shali Mazaki‐Tovi, Pooja Mittal, Jimmy Espinoza et al. · 2008 · The Journal of Maternal-Fetal & Neonatal Medicine
  59. Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia
    Sarosh Rana, Ana Sofia Cerdeira, Julia Wenger, Saira Salahuddin, Kee-Hak Lim, Steven J. Ralston, Ravi Thadhani, S. Ananth Karumanchi · 2012 · PLoS ONE
  60. Decreased expression of apelin in placentas from severe pre-eclampsia patients
    Hiromi Inuzuka, Haruki Nishizawa, Ayaka Inagaki, Machiko Suzuki, Sayuri Ota, Hironori Miyamura, Jun Miyazaki, Takao Sekiya, Hiroki Kurahashi, Yasuhiro Udagawa · 2013 · Hypertension in Pregnancy
  61. Endothelial Dysfunction in Pregnancy Complications
    Jakub Kornacki, Paweł Gutaj, Anastasia Kalantarova, Rafał Sibiak, Maurycy Jankowski, Ewa Wender-Ożegowska · 2021 · Biomedicines
  62. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application
    Olav Lapaire, Andrew H. Shennan, Holger Stepan · 2010 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  63. Maternal circulating angiogenic factors in twin and singleton pregnancies
    Jessica M. Faupel‐Badger, Thomas Frederick McElrath, Michele R. Lauria, Lauren C. Houghton, Kee-Hak Lim, Samuel I. Parry, David E. Cantonwine, Gabriel Y. Lai, S. Ananth Karumanchi, Robert N. Hoover et al. · 2014 · American Journal of Obstetrics and Gynecology
  64. Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation
    Abdelouahab Bakhti, Daniel Vaiman · 2011 · Hypertension Research
  65. Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia
    Hernan D. Kopcow, S. Ananth Karumanchi · 2007 · Journal of Reproductive Immunology
  66. Biomarkers in pre-eclampsia: A novel approach to early detection of the disease
    Sophia Masoura, Ioannis A Kalogiannidis, Georgios Gitas, A. Goutsioulis, Ekaterini Koiou, Apostolos P Athanasiadis, Norma A. Vavatsi · 2012 · Journal of Obstetrics and Gynaecology
  67. Novel Interventions for the Prevention of Preeclampsia
    Marwan Ma’ayeh, Kara M. Rood, Douglas A. Kniss, Maged M. Costantine · 2020 · Current Hypertension Reports
  68. Expert review: preeclampsia Type I and Type II.
    Yagel, Simcha, Cohen, Sarah M., Admati, Inbal, Skarbianskis, Niv, Solt, Ido, Zeisel, Amit, Beharier, Ofer, Goldman-Wohl, Debra · 2023 · American Journal of Obstetrics & Gynecology MFM
  69. Retinol binding protein 4 – a novel association with early-onset preeclampsia
    Edi Vaisbuch, Roberto J. Romero, Shali Mazaki‐Tovi, Offer Erez, Sun Kwon Kim, Tinnakorn Chaiworapongsa, Francesca Gotsch, Nándor Gábor Than, Zhong Dong, Percy Pacora et al. · 2009 · Journal of Perinatal Medicine
  70. Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks
    Antonio Farina, Cinzia Zucchini, Akihiko Sekizawa, Yuditiya Purwosunu, Paola De Sanctis, Giuseppe Santarsiero, Nicola Rizzo, Danila Morano, Takashi Okai · 2010 · American Journal of Obstetrics and Gynecology
  71. Pyogenic granuloma, an impaired wound healing process, linked to vascular growth driven by FLT4 and the nitric oxide pathway
    Catherine Godfraind, Monica L. Calicchio, Harry P. Kozakewich · 2012 · Modern Pathology
  72. Modification of angiogenic factors by regular and acute exercise during pregnancy
    Tracey Lynn Weissgerber, Gregory Davies, James Michael Roberts · 2010 · Journal of Applied Physiology
  73. Tissue factor and its natural inhibitor in pre-eclampsia and SGA
    Offer Erez, Roberto J. Romero, Debra Hoppensteadt, Nándor Gábor Than, Jawed Fareed, Shali Mazaki‐Tovi, Jimmy Espinoza, Tinnakorn Chaiworapongsa, Sung-Su Kim, Bo Hyun Yoon et al. · 2008 · The Journal of Maternal-Fetal & Neonatal Medicine
  74. Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma
    Yuditiya Purwosunu, Akihiko Sekizawa, Shiho Okazaki, Antonio Farina, Noroyono Wibowo, Masamitsu Nakamura, Nicola Rizzo, Hiroshi Saito, Takashi Okai · 2009 · American Journal of Obstetrics and Gynecology
  75. miR‐342‐5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling
    Xianchun Yan, Jing Cao, Liang Liang, Li Wang, Fang Gao, Ziyan Yang, Juanli Duan, Tianfang Chang, San‐Ming Deng, Yuan Liu et al. · 2016 · Journal of the American Heart Association
  76. Evaluation of blood vessel injury, oxidative stress and circulating inflammatory factors in an L‑NAME‑induced preeclampsia‑like rat model
    Wen Shu, Hanying Li, Hao Gong, Mei Zhang, Xiulong Niu, Yongqiang Ma, Xin Zhang, Wei Cai, Guo-Hong Yang, Maoti Wei et al. · 2018 · Experimental and Therapeutic Medicine
  77. Cytomegalovirus-Induced Mirror Syndrome Associated With Elevated Levels of Circulating Antiangiogenic Factors
    Sarosh Rana, Shivalingappa Venkatesha, Monique E. DePaepe, Edward K. Chien, Michael J. Paglia, S. Ananth Karumanchi · 2007 · Obstetrics and Gynecology
  78. Defective Uteroplacental Vascular Remodeling in Preeclampsia: Key Molecular Factors Leading to Long Term Cardiovascular Disease
    Kirim Hong, Soo Hyun Kim, Dong Hyun Cha, Hee Jin Park · 2021 · International Journal of Molecular Sciences
  79. Epistasis between COMT and MTHFR in Maternal-Fetal Dyads Increases Risk for Preeclampsia
    Lori D. Hill, Timothy P. York, Juan Pedro Kusanovic, Ricardo Gómez, Lindon J. Eaves, Roberto J. Romero, Jerome F. Strauss · 2011 · PLoS ONE
  80. A Review of Gene Expression in Porcine Endometrial Lymphocytes, Endothelium and Trophoblast During Pregnancy Success and Failure
    Chandrakant Tayade, Yuan Fang, Barbara Anne Croy · 2007 · Journal of Reproduction and Development
  81. Endothelial microvesicles carrying Src-rich cargo impair adherens junction integrity and cytoskeleton homeostasis
    Victor Chatterjee, Xiaoyuan Yang, Yonggang Ma, Byeong Cha, Jamie E. Meegan, Mack H. Wu, Sarah Y. Yuan · 2019 · Cardiovascular Research
  82. A double hit preeclampsia model results in sex-specific growth restriction patterns
    Violeta Stojanovska, Dorieke J. Dijkstra, Rebekka Vogtmann, Alexandra Gellhaus, Sicco A. Scherjon, Torsten Plösch · 2019 · Disease Models & Mechanisms
  83. Systemic transcriptome comparison between early‐ And late‐onset pre‐eclampsia shows distinct pathology and novel biomarkers
    Fang Guo, Bao Zhang, Hao Yang, Yixi Fu, Yaning Wang, Jianming Huang, Mi Cheng, Xiaobo Li, Zhuojian Shen, Li Li et al. · 2020 · Cell Proliferation
  84. Compartmentalizing VEGF-Induced ERK2/1 Signaling in Placental Artery Endothelial Cell Caveolae: A Paradoxical Role of Caveolin-1 in Placental Angiogenesis in Vitro
    Wu-xiang Liao, Lin Feng, Honghai Zhang, Jing Juan Zheng, Thomas R. Moore, Dong‐bao Chen · 2009 · Molecular Endocrinology
  85. Twin-to-twin transfusion syndrome: an antiangiogenic state?
    Juan Pedro Kusanovic, Roberto J. Romero, Jimmy Espinoza, Jyh Kae Nien, Chong Jai Kim, Pooja Mittal, Samuel S. Edwin, Offer Erez, Francesca Gotsch, Shali Mazaki‐Tovi et al. · 2008 · American Journal of Obstetrics and Gynecology
  86. Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia
    Seth M. Guller, Catalin Sorin Buhimschi, Yula Y Ma, S.‐T. Joseph Huang, Liubin Yang, Edward Kuczynski, Eduardo V. Zambrano, Charles Joseph Lockwood, Irina Alexandra Buhimschi · 2008 · Laboratory Investigation
  87. Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin
    Tu’uhevaha J. Kaitu’u‐Lino, Stephen Y. C. Tong, Sally Beard, Roxanne M. Hastie, Laura Tuohey, Fiona Brownfoot, Kenji Onda, Natalie J. Hannan · 2014 · Pregnancy Hypertension
  88. Preeclampsia and Retinopathy of Prematurity in Preterm Births
    Xiao Dan Yu, David Ware Branch, S. Ananth Karumanchi, Jun Zhang · 2012 · PEDIATRICS
  89. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy
    Minglin Zhu, Zongli Ren, José Sérgio Possomato‐Vieira, Raouf A. Khalil · 2016 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  90. Serum Exosome Isolation by Size-Exclusion Chromatography for the Discovery and Validation of Preeclampsia-Associated Biomarkers
    Rosana Navajas, Fernando José Corrales, Alberto Paradela · 2019 · Methods in molecular biology
  91. Advances in the understanding of eclampsia
    S. Ananth Karumanchi, Marshall D. Lindheimer · 2008 · Current Hypertension Reports
  92. From Biomarkers to the Molecular Mechanism of Preeclampsia—A Comprehensive Literature Review
    Magda Rybak-Krzyszkowska, Jakub Staniczek, Adrianna Kondracka, Joanna Bogusławska, Sebastian Kwiatkowski, Tomasz Góra, Michał Strus, Wojciech Górczewski · 2023 · International Journal of Molecular Sciences
  93. Soluble endoglin, hypercholesterolemia and endothelial dysfunction
    Jana Rathouska, Kateřina Ježková, Ivana Němečková, Petr Nachtigal · 2015 · Atherosclerosis
  94. Adenosine and preeclampsia
    Rocío Salsoso, Marcelo Farías, Jaime Gutiérrez, Fabián Pardo, Delia Indira Chiarello, Fernando Toledo, Andrea Leiva, Alfonso Mate, Carmen María Vázquez, Luis Sobrevía · 2017 · Molecular Aspects of Medicine
  95. Elucidating the Pathogenesis of Pre-eclampsia Using In Vitro Models of Spiral Uterine Artery Remodelling
    Ross P. McNally, Abdelrahim M. Alqudah, Danilo D. Obradović, Lana McClements · 2017 · Current Hypertension Reports
  96. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction
    Fiona Brownfoot, Natalie J. Hannan, Ping Cannon, Vi Nguyen, Roxanne M. Hastie, Laura J. Parry, Sevvandi N. Senadheera, Laura Tuohey, Stephen Y. C. Tong, Tu’uhevaha J. Kaitu’u‐Lino · 2019 · EBioMedicine
  97. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis
    Nicola E. Owen, Graeme Alexander, Sambit Sen, Katherine Bunclark, Gary John Polwarth, Joanna Pepke‐Żaba, Anthony P. Davenport, Nicholas W. Morrell, Paul D. Upton · 2020 · EBioMedicine
  98. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia
    Young Nam Kim, Dae Shim Lee, Dae Hoon Jeong, Moon Su Sung, Ki Tae Kim · 2009 · Prenatal Diagnosis
  99. Review: The feto-placental unit, pregnancy pathology and impact on long term maternal health
    Vicki Lee Clifton, Michael John Stark, Annette Osei-Kumah, Nicolette A. Hodyl · 2011 · Placenta
  100. New markers in preeclampsia
    Alexandre Hertig, Philippe Lière · 2010 · Clinica Chimica Acta